Wegovy Prices in the UK: What the Numbers Actually Mean

Why do Wegovy prices vary so much between providers?

The short answer is that they are pricing different things. Some advertised figures cover only the pen; others bundle in consultation fees, the prescription itself, delivery and aftercare. When you strip a price down to the bare pen cost and pay separately for everything else, the totals often converge, or the cheaper-looking option turns out to be more expensive once you add clinical review charges, delivery fees and follow-up costs.

Dose is the bigger driver. Wegovy starts at 0.25 mg and is titrated by a prescriber upward through 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, with 7.2 mg now also approved by the MHRA following the single-dose 7.2 mg pen approval in April 2026. A patient at 0.5 mg pays significantly less than one who has reached 2.4 mg, so the "Wegovy price" you read about in one place may refer to a completely different dose than the figure quoted elsewhere.

Since Novo Nordisk adjusted UK list pricing in autumn 2025, private prices at the higher doses have moved upward across the market. Reported private costs since then range roughly £149 to £375 per month by dose and provider, though these figures shift, and if you want to understand what drives the variation in more detail, the Wegovy prive breakdown covers the key factors clearly. For a factual overview of what's included in one clear monthly price, the Wegovy treatment page sets that out plainly.

Does the cheapest Wegovy price mean the worst option?

Not automatically, but the cheapest listing carries risks worth thinking through carefully. Wegovy is a prescription-only medicine. Supplying it legally in the UK requires a valid prescription issued following genuine clinical assessment. A provider offering it at a price that seems disconnected from the market reality for a prescription medicine is worth scrutinising: how is clinical review handled, by whom, and what happens if you have a side effect at 9pm on a Sunday?

The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online. In one operation alone, around 20 million doses of illegally traded weight-loss medicines (with an estimated street value of around £45 million) were seized. Fake pens have been found to contain insulin rather than semaglutide, with predictably dangerous consequences. You can verify any online pharmacy by searching the GPhC register, a legitimate dispensing pharmacy will appear there with a premises registration number.

On that note: a seller offering Wegovy or any similar medicine without requiring a proper prescription is a serious red flag. So is a discount code from a seller you found via social media. For more on the safety signals to watch for, the side of Wegovy that providers don't always discuss is worth reading before you commit to any service.

What about Wegovy on the NHS, is that not free?

It can be, but access is narrow. NICE recommends semaglutide (Wegovy) under technology appraisal TA875 for adults within specialist weight management services, for a maximum of two years, with a BMI of 35 or above plus at least one weight-related condition (30–34.9 with conditions also considered in certain circumstances). Ethnic background adjustments lower these thresholds by 2.5 kg/m² for some groups. NHS prescriptions also require participation in wraparound diet and activity support.

In practice, NHS waiting lists for specialist weight management services are long in most parts of England. The rollout is real but gradual. If you are wondering whether you qualify, or simply cannot wait, a private prescription through a GPhC-registered pharmacy is the route most people take. Worth planning around if you can: orders placed before midday on a working day tend to move fastest, something to keep in mind if payday or a bank holiday is looming.

Scotland, Wales and Northern Ireland run their own arrangements; eligibility criteria differ, so if you're outside England, local NHS guidance applies. For a fuller picture of what private treatment involves and how to start a clinical assessment, exploring the treatment options page is the natural next step.

Are there any legitimate ways to reduce the cost?

The honest answer is: not many, and not in the way the question usually implies. nume doesn't run discount codes or promotional offers for prescription medicines; no legitimate regulated pharmacy should, and a code attached to a POM from an unverified seller is precisely the kind of signal the MHRA asks people to treat with suspicion.

What does reduce the effective cost is choosing a provider where clinical review, the prescription, delivery and aftercare are bundled into one price, because none of those extras land separately at checkout. Some people also find that once they reach a stable maintenance dose and their appetite settles, they are managing well at a lower dose than the maximum, which naturally reduces the monthly cost. That is a clinical conversation, not a self-directed one; your prescriber can advise based on your progress.

For context on what semaglutide actually does in the body and why it works the way it does, the semaglutide overview covers the mechanism clearly. And if skin reactions or other unexpected responses are part of your thinking around costs and tolerability, the page on semaglutide hives and how they present addresses that specifically, with the hives and allergic responses to Wegovy page covering further detail. Our clinical team is reachable seven days a week if a question comes up mid-treatment, details on the contact page.